“The effectiveness of new hormone therapy treatments on progression-free survival of patients with HR+/HER2- metastatic breast cancer: a systematic review”, RSD, vol. 10, no. 14, p. e85101421940, Oct. 2021, doi: 10.33448/rsd-v10i14.21940.